Zenlabs Ethica (BOM:530697) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530697 Zenlabs Ethica Ltd BOM:530697
55 GF Score
Price ₹25.80
GF Value ₹28.91
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Zenlabs Ethica Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

BOM:530697
55GF Score
Zenlabs Ethica Ltd BOM:530697
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zenlabs Ethica (BOM:530697) Overvalued in 2026?

Based on GuruFocus' analysis, Zenlabs Ethica stock appears to be undervalued. The current stock price of ₹25.80 is trading 10.8% below its estimated GF Value™ of ₹28.91. GuruFocus considers Zenlabs Ethica to be Modestly Undervalued.

Key valuation signals for BOM:530697:

  • Dividends Received:
  • GF Value™: ₹28.91 vs. price of ₹25.80 (10.8% below fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the BOM:530697 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zenlabs Ethica Business Description

Address Plot No.194-195, 3rd Floor, Industrial Area, Phase-II, Ram Darbar, Chandigarh, IND, 160002
Zenlabs Ethica Ltd is a pharmaceutical company engaged in the trading of pharmaceutical formulations. It manufactures and markets drugs which include Gastrointestinal disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps, and anti-Bacterial drugs, nutraceuticals, and others. In addition, The company offers more than 600 products across therapeutic segments.
55GF Score

Get the complete analysis for BOM:530697

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹25.80
Price
₹28.91
GF Value